NCT01969227View on ClinicalTrials.gov

The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Mechanical VentilationAirway PatencyRespiratory Depression
Interventions
DRUG

Subanesthetic ketamine

Ketamine drip at a subanesthetic infusion rate (low dose ketamine 5 - 10 mcg/kg/min)

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01969227 - The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures | Biotech Hunter | Biotech Hunter